ArticleFrontiers in cardiovascular medicine2025
Prognostic value of diabetes mellitus for acute type B intramural hematoma patients undergoing endovascular repair.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Thoracic endovascular aortic repair (TEVAR) is increasingly performed in patients with acute type B intramural hematoma (IMH). This study aimed to evaluate the effect of diabetes mellitus (DM) on postoperative clinical outcomes and aortic remodeling degree of acute type B IMH patients undergoing endovascular repair. Methods: We retrospectively identified patients diagnosed with acute type B IMH at two medical centers between January 2017 and January 2024. Study subjects were divided into DM and none DM (nDM) groups. Baseline characteristics, procedure details, and postoperative outcomes were extracted for further analysis. Results: Forty-four patients were included in the study and were divided into DM ( Conclusions: DM is positively associated with the prognosis of patients with acute type B IMH undergoing TEVAR and promotes postoperative aortic remodeling. Moreover, a TAD/TLD ratio >1.32 independently predicts the incidence of postoperative MAE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.